Net profit of Gujarat Terce Laboratories declined 32.50% to Rs 0.54 crore in the quarter ended March 2024 as against Rs 0.80 crore during the previous quarter ended March 2023. Sales declined 5.28% to Rs 12.21 crore in the quarter ended March 2024 as against Rs 12.89 crore during the previous quarter ended March 2023.For the full year,net profit reported to Rs 0.24 crore in the year ended March 2024 as against net loss of Rs 1.67 crore during the previous year ended March 2023. Sales rose 2.54% to Rs 47.97 crore in the year ended March 2024 as against Rs 46.78 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales12.2112.89 -5 47.9746.78 3 OPM %8.19-1.47 -2.65-4.62 - PBDT0.93-0.26 LP 0.91-2.53 LP PBT0.84-0.42 LP 0.54-2.89 LP NP0.540.80 -33 0.24-1.67 LP Powered by Capital Market - Live News

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 29 May 2024Powered by Capital Market - Live News

Gujarat Terce Laboratories announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 25 April 2024 .Powered by Capital Market - Live News

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on 29 March 2024.Powered by Capital Market - Live News

Net profit of Gujarat Terce Laboratories reported to Rs 0.67 crore in the quarter ended December 2023. There were no net profit/loss reported during the previous quarter ended December 2022. Sales rose 9.41% to Rs 13.02 crore in the quarter ended December 2023 as against Rs 11.90 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales13.0211.90 9 OPM %6.451.09 - PBDT0.760.07 986 PBT0.670 0 NP0.670 0 Powered by Capital Market - Live News